osimertinibosimertinib-inducedNSCLCnon-small cell lung cancerLewis lung cancer
… with identical EGFR mutations. This study investigates whether osimertinib, a third-generation EGFR-TKI, activates the nucleotide-binding …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: osimertinib-induced ×
osimertinib-induced
This drug is selected. Its supporting articles are shown below.